Literature DB >> 30325052

Electrical properties tomography: Available contrast and reconstruction capabilities.

Ileana Hancu1, Jiaen Liu2, Yihe Hua1, Seung-Kyun Lee3,4.   

Abstract

MR-based electrical properties tomography converts the MRI transmit/receive RF field measurements to tissue electrical property maps through dedicated reconstruction algorithms. Recent reports showed that despite limitations, electrical properties tomography holds promise for generating additional contrast for tumor detection and patient-specific modeling of tissue-RF field interactions. This review summarizes the available tissue electrical property contrasts and compares them with the capabilities of the most commonly used electrical properties tomography reconstruction method. Future directions and prospects of clinical translation are discussed.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  B1 map; EPT; MREPT; bioimpedance; cancer; conductivity; electrical properties tomography; permittivity

Mesh:

Substances:

Year:  2018        PMID: 30325052     DOI: 10.1002/mrm.27453

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  Automated gradient-based electrical properties tomography in the human brain using 7 Tesla MRI.

Authors:  Yicun Wang; Pierre-Francois Van de Moortele; Bin He
Journal:  Magn Reson Imaging       Date:  2019-08-16       Impact factor: 2.546

2.  Brain Tissue Conductivity Measurements with MR-Electrical Properties Tomography: An In Vivo Study.

Authors:  Stefano Mandija; Petar I Petrov; Jord J T Vink; Sebastian F W Neggers; Cornelis A T van den Berg
Journal:  Brain Topogr       Date:  2020-12-08       Impact factor: 3.020

3.  Decomposition of high-frequency electrical conductivity into extracellular and intracellular compartments based on two-compartment model using low-to-high multi-b diffusion MRI.

Authors:  Mun Bae Lee; Hyung Joong Kim; Oh In Kwon
Journal:  Biomed Eng Online       Date:  2021-03-25       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.